Prof. Mella - Autoimmunity and metabolism in ME/CFS (lecture)

English subtitles added.

The talk is about autoimmunity and metabolism. Mella also mentions RituxME and CycloME.

CycloME has preliminary good data, it appears - and they are planning to do a double blind study on cyclophosphamide.

Mella strongly advises against testing treatments outside of clinical trials.
 
This is a highly interesting video! He talks about so much different topics: Metabolics findings (Naviaux, pyruvate kinase, high lactate levels, also in the brain), the study where they combined grown muscle cells and blood by ME people, vascular stuff, orthostatic intolerance and many more.
 
Inara said:
This is a highly interesting video! He talks about so much different topics: Metabolics findings (Naviaux, pyruvate kinase, high lactate levels, also in the brain), the study where they combined grown muscle cells and blood by ME people, vascular stuff, orthostatic intolerance and many more.
Click to expand...

Thanks Inara, that sounds fascinating, can't wait to see it when they get the sub-titles.
 
thank you for the subtitles.

my fogged review:

vascular. could account for multisystemness.

metabolism also. much bigger study than naviaux. men and women different as we knew.

autoimmune not certain if only at one stage or at all stages. [or similar. seemed to say m.e. is autoimmune.]

men and women different because women need to ease up on attacking foreign stuff for child. [i knew this but forgot why this makes sense. why wouldn't men be more autoimmune then?]

ritux negative but still subset is possible. but not distinguishable clinically.

nausea in cyclo is /not/ just a generally problematic drug. m.e. gets more nausea. [why?]

something in our serum.

impression: real scientist. seriously working on m.e. wants to /know/. no nonsense. doesn't focus on just a couple of systems to fit his theory; fits theory to facts. need more people like this guy.
 
Last edited:
BurnA said:
For cancer trials I don't think placebos are used, the outcome is usually 100% objective so blinding is less important.
Click to expand...
I was a chemo nurse administering clinical trials. In blinded trials, patients would receive pre-meds as per protocol because remember, even the staff would not be aware what they are administering, but assuming for safety reason that the patient recieved the real medication). And yes placebos are used in oncology but these days the bulk of the clinical trials compare a treatment regimen against another. Since they are drug cocktails (example, cytotoxic and biologic versus cytotoxic alone) pre-medication is the same for both treatment lines.

In this case, Cyclophosphamide vs placebo, there will be patients in the placebo group experiencing nausea simply because they believe they have received the chemo drug. Regardless, the investigators are likely to premedicate everybody with the same nausea medication before the infusion, and use a nausea protocol (take x pill every 4 hours if nauseated) for after the infusion for everyone. I am not totally sure how long patients with ME will feel nausea for, but usually for a low dose Cyclophosphamide, it is never much more than 48 hours if that.

My 2 cents.

Edit to add: the placebo response being what it is, you will have patients who feel much better a few days after getting their infusion and believing for sure theygot the real deal. We will find out when they publish again. Fortunately it is not as long a trial as for Rituximab.
 
Last edited:
You must log in or register to reply here.
Back
Top Bottom